Cite
An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen.
MLA
Andersen, T. T., et al. “An Alpha-Fetoprotein-Derived Peptide Reduces the Uterine Hyperplasia and Increases the Antitumour Effect of Tamoxifen.” British Journal of Cancer, vol. 97, no. 3, Aug. 2007, pp. 327–33. EBSCOhost, https://doi.org/10.1038/sj.bjc.6603882.
APA
Andersen, T. T., Georgekutty, J., Defreest, L. A., Amaratunga, G., Narendran, A., Lemanski, N., Jacobson, H. I., & Bennett, J. A. (2007). An alpha-fetoprotein-derived peptide reduces the uterine hyperplasia and increases the antitumour effect of tamoxifen. British Journal of Cancer, 97(3), 327–333. https://doi.org/10.1038/sj.bjc.6603882
Chicago
Andersen, T T, J Georgekutty, L A Defreest, G Amaratunga, A Narendran, N Lemanski, H I Jacobson, and J A Bennett. 2007. “An Alpha-Fetoprotein-Derived Peptide Reduces the Uterine Hyperplasia and Increases the Antitumour Effect of Tamoxifen.” British Journal of Cancer 97 (3): 327–33. doi:10.1038/sj.bjc.6603882.